News

Dr Burkhoff has served as CircuLite’s medical director and as a chairman of the scientific advisory board (SAB) since its inception in 2005, and he will continue to

Praxis will complete the reimbursement application for Aridol in France and thereafter market the product to hospital specialists. Alan Robertson, CEO of Pharmaxis, said: “We are delighted to

The milestone payment arises from an ongoing research collaboration aimed at identifying human antibodies against intractable targets. Pepscan is responsible for using its Chemically linked Peptides on Scaffolds

Under this collaboration, the companies are developing novel therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD). After nominating the first candidate drug AZD1419, expected

Voyager NC is now available in the US, Europe and select countries in Asia and Latin America. Featuring Abbott’s technology, the new Voyager NC system can be used

Mr Condella is a non-executive director of Skyepharma and Fulcrum Pharma. Mr Condella was CEO of Skyepharma from March 2006 to September 2008, president of European operations at

The US medical device operations will be overseen by Efraim Kozorovitsky, executive director of medical devices, and a four-year veteran of the company. Mr Roe has relocated from

Mr Stocks brings substantial experience and expertise to lead Calistoga Pharmaceuticals’s business and corporate development strategy, and business practices. Mr Stocks will be responsible for corporate/business development, finance

The Female Health Company’s lower-cost second generation female condom will now be available for purchase and distribution in the US. The FDA approval will also enable the US